GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity.

GLP-1 agonist drugs treat diabetes by balancing blood glucose levels. Here’s our list of GLP-1 agonists, how they work, similarities and differences, and more.

Oct 29, 2025 · Browse our GLP-1 drug list of incretin mimetics, including: Ozempic, Wegovy, and Rybelsus. Compare doses, side effects, user reviews, and more.

Jun 1, 2025 · Below is a detailed list of GLP-1 receptor agonist drugs, including all FDA-approved, new, injectable, and oral medications, along with brief reviews of each drug’s unique features.

1 day ago · GLP-1 drugs have emerged as a revolutionary treatment option for individuals battling both type 2 diabetes and obesity. These medications, which include semaglutide, liraglutide, …

Jul 14, 2025 · Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are …

May 21, 2025 · See the latest 2025 overview of GLP-1 drugs: history, how they work, full medication list, and pipeline updates—plus clinical pearls for safe, effective use.

Learn about GLP-1 agonists, a class of medications used to manage type 2 diabetes and obesity. Discover their benefits, how they work, side effects and more.

GLP-1 receptor agonist Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 agonists, GLP-1RAs, GLP-1 analogs, or incretin mimetics, are a class of medications that …